Robert DeWit

Robert DeWit

Président chez
ACP Northern Holdings LLC
Commercial Services
Finance
Health Technology

Profil

Dr. Rob DeWit is an operating advisor at Avista Capital Partners.
Dr. DeWit is an industry leader who has dedicated more than 35 years to advancing global healthcare, by serving in scientific and leadership roles for Warner-Lambert, Upjohn, Pharmacia, Pfizer, and the WMU Homer Stryker MD School of Medicine Innovation Center.
Dr. DeWit most recently served as the President and CEO of MPI Research, a former Avista IV portfolio company sold in 2018 to Charles River Laboratories.
Dr. DeWit has extensive experience with non-clinical drug development and corporate cultural change.
Dr. DeWit received a B.S.
from Calvin College and a PhD in Toxicology from The University of Michigan.
He currently serves as Chairman of the Board of ACP Northern Holdings and on the board of Taconic Biosciences, and previously served as a Director of Inform Diagnostics.

Postes actifs de Robert DeWit

SociétésPosteDébut
Consultant / Advisor -
R H Dewit Consulting, LLC
Corporate Officer/Principal 01/04/2018
ACP Northern Holdings LLC
Président -
Directeur/Membre du Conseil -

Anciens postes connus de Robert DeWit

SociétésPosteFin
President 01/04/2018
Directeur Général 01/03/2016
Directeur/Membre du Conseil 01/10/2008
Directeur/Membre du Conseil 01/12/2006
Directeur/Membre du Conseil 01/07/1999
Voir l'expérience en détail de Robert DeWit

Formation de Robert DeWit

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

88

Relations au 1er degré

18

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées18

Finance

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Services

Finance

Commercial Services

Commercial Services

Upjohn Laboratories LLC

Finance

Commercial Services

Commercial Services

Commercial Services

R H Dewit Consulting, LLC

ACP Northern Holdings LLC

  1. Bourse
  2. Insiders
  3. Robert DeWit
🔇